Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6818-06.
Published March 11, 2026 · Recall initiated: February 17, 2026
Summary
FDA records drug Class II recall D-0383-2026, published March 11, 2026 and initiated February 17, 2026. Recalling firm: The Harvard Drug Group LLC; Status: Ongoing; Reported quantity: 8892 cartons; Lot: Lot # N02640, Exp Date: 08/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective container; inadequately sealed blister packaging.
What to do
Voluntary: Firm initiated · Letter
Get an email if MIDODRINE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- MIDODRINE HYDROCHLORIDE
- Manufacturer
- The Harvard Drug Group LLC
- Distributor
- Nationwide US.
- Lot
- Lot # N02640, Exp Date: 08/2027
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDANilotinib Capsules, 200 mg per capsule, packaged in cartons, Rx only, Manufactured for: Cipla USA, Inc., 10March 11, 2026
- FDAProduct label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: RisingMarch 11, 2026
- FDANilotinib Capsules, 150 mg per capsule, packaged in cartons, Rx only, Manufactured by: Cipla Ltd., Verna, Goa,March 11, 2026
- FDAFIVE-STAR, VASOCAINE Spray, (Lidocaine HCl 4%, Racepinephrine HCl 0.01%), 4oz bottles, Distributed By: DermalMarch 11, 2026
- FDASemaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c)March 11, 2026
- FDAMAXIMUM, ZONE 1, 4% Lidocaine Cream, 1/2 oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDCMarch 11, 2026
Questions about this recall
Was Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6818-06. recalled?
Yes. FDA published recall D-0383-2026 on March 11, 2026. Reported hazard: Defective container; inadequately sealed blister packaging.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: MIDODRINE HYDROCHLORIDE.